Zio AT ECG Monitoring System vs Fetal EchoScan

The Zio AT system streamlines arrhythmia detection by providing continuous, long-term ECG monitoring via a wearable patch and wireless gateway, culminating in comprehensive end-of-wear reports for clinicians. This allows for efficient identification of both symptomatic and asymptomatic cardiac events over an extended period. Fetal EchoScan optimizes prenatal ultrasound examinations by offering real-time AI-driven guidance and feedback directly on a cart-side tablet display, ensuring exam completeness and standardization of fetal heart assessments. This integration helps clinicians achieve optimized workflow and faster reading times.

The Zio AT system offers seamless EHR integration, including with Epic via the Aura network, allowing for electronic ordering, streamlined workflows, and the delivery of Zio end-of-wear reports directly into the EHR. This integration can eliminate manual steps and provide discrete data for over 195 fields. Fetal EchoScan is designed for seamless integration with existing ultrasound machines and reporting solutions, being DICOM compatible. This allows it to fit into current imaging workflows and transfer data to reporting systems, with the downstream surfacing of results in the EHR typically handled by the cardiology reporting system or PACS.

The Zio AT system utilizes an FDA-cleared deep-learned AI algorithm (ZEUS System) for continuous, uninterrupted ECG recording up to 14 days, designed to detect a wide range of symptomatic and asymptomatic cardiac events. Studies have shown it has a high diagnostic yield for arrhythmias, including atrial fibrillation, and can provide over 95% accuracy in PVC burden categorization with at least seven days of monitoring. Fetal EchoScan employs AI-powered ultrasound screening software to assist in the prenatal detection of congenital heart defects, with claims of reducing false-negative and false-positive errors and ensuring exam completeness. While general fetal echocardiography has high diagnostic accuracy for major CHDs, particularly with trained practitioners, the AI aims to standardize and improve this process.

For the Zio AT system, clinicians primarily learn to interpret comprehensive end-of-wear reports and navigate the ZioSuite clinician portal, while patients use a simple wearable patch and MyZio mobile app. The system is designed for ease of use to promote patient compliance. Fetal EchoScan integrates with existing ultrasound workflows and provides real-time guidance on a cart-side tablet display, suggesting a relatively low learning curve for sonographers already proficient in ultrasound. Studies on fetal heart ultrasound assessment indicate that it is a relatively simple procedure to learn, with proficiency in assessing fetal structures achievable after scanning about 50 cases.

The Zio AT system generates comprehensive end-of-wear reports, which serve as a detailed record of detected cardiac events and monitoring data, providing a clear audit trail of the patient's ECG activity and findings. The ZioSuite clinician portal would also likely log user activity for report access and interpretation. Fetal EchoScan's AI-driven guidance aims to ensure exam completeness and standardization of fetal heart assessments, which inherently creates a more structured and auditable record of the ultrasound process. Its DICOM compatibility with reporting solutions further supports auditability within existing imaging and record-keeping systems.

Value from the Zio AT system is realized through its ability to provide continuous, long-term arrhythmia detection over up to 14 days, leading to comprehensive diagnostic reports that inform treatment decisions and can reduce the time to treatment. Operational benefits include reduced staff burden and streamlined workflows compared to traditional monitoring methods. Fetal EchoScan offers immediate operational value by optimizing workflow and enabling faster reading times during prenatal ultrasound examinations, while also enhancing clinical value by ensuring exam completeness and reducing diagnostic errors in real-time. This real-time assistance can lead to more confident interpretations and improved efficiency during the scan itself.